Type
Takata, Sada, Ozawa, Sekiguchi. HLA and mycobacterial infection: increased frequency of B8 in Japanese leprosy. Tissue antigens. 1978;11(1):61-4.
Type
De Cock, Wilkinson. Tuberculosis control in resource-poor countries: alternative approaches in the era of HIV. Lancet (London, England). 1995;346(8976):675-7.
Type
Jagannath, Reddy, Kailasam, O'Sullivan, Gangadharam. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. American journal of respiratory and critical care medicine. 1995;151(4):1083-6.
Type
Lagrange. [A very current aspect of the fate of infectious diseases: tuberculosis, leprosy and opportunistic mycobacteria]. Bulletin de l'Academie nationale de medecine. 1995;179(4):805-20; discussion 820-2.
Type
Bermudez, Kaplan. Recombinant cytokines for controlling mycobacterial infections. Trends in microbiology. 1995;3(1):22-7.
Type
Bermudez. Use of liposome preparation to treat mycobacterial infections. Immunobiology. 1994;191(4-5):578-83.
Type
Kaplan. Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiology. 1994;191(4-5):564-8.
Type
Bretscher. Prospects for low dose BCG vaccination against tuberculosis. Immunobiology. 1994;191(4-5):548-54.
Type
Chaturvedi, Singh, Sinha. Immunoreactive antigens of a candidate leprosy vaccine: Mycobacterium habana. Leprosy review [Internet]. 1995;66(1):31-8. Available from: http://leprev.ilsl.br/pdfs/1995/v66n1/pdf/v66n1a05.pdf
Type
Blackwell, Barton, White, Roach, Shaw, Whitehead, et al. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunology letters. 1994;43(1-2):99-107.